{"meta":{"query_hash":"8cebc2dd487b","filters":{"venue":"Current Hematologic Malignancy Reports"},"cohort_total":33,"direct_labels_cover":0,"predictions_cover":33,"exported":33,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8cebc2dd487b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Hematologic+Malignancy+Reports"},"results":[{"id":"W1944062703","doi":"10.1007/s11899-015-0287-9","title":"Social Media and Myeloproliferative Neoplasms (MPN)—Focus on Twitter and the Development of a Disease-specific Community: #MPNSM","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Texas MD Anderson Cancer Center; Incyte; National Cancer Institute; Gilead Sciences","keywords":"Social media; Medicine; Public relations; Citation; Focus group; Health care; Internet privacy; Political science; World Wide Web; Business; Computer science; Marketing","score_opus":0.1813166460235479,"score_gpt":0.373956349976804,"score_spread":0.19263970395325608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1944062703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004139363,0.9972133,0.000043686956,0.0007751904,0.00025883704,0.000006158901,0.00005714816,0.0000040464543,0.0012277378],"genre_scores_gemma":[0.0028370162,0.9958509,0.00011103756,0.00034627653,0.0003290392,0.000006604068,0.000054915392,0.0000010609746,0.0004631209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979264,0.000051844905,0.00003962279,0.000031731957,0.0000646168,0.000019594736],"domain_scores_gemma":[0.9991252,0.00052693667,0.0001801417,0.0000100813295,0.000103171784,0.000054614447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045734295,0.00041689072,0.0006325247,0.0018862581,0.0002709205,0.0011074608,0.00039483994,0.0008813496,0.0050668833],"category_scores_gemma":[0.0013021518,0.00015679446,0.0005818321,0.00202178,0.00032625158,0.0014258417,0.00075007125,0.0009108038,0.00092436397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006948235,0.000047734255,0.0024460058,0.027075987,0.00018063145,0.00017186716,0.00020256617,0.00009154559,0.00041886073,0.0028989618,0.028678264,0.93771803],"study_design_scores_gemma":[0.00002210349,0.00010319274,0.009557833,0.024545409,0.0004888448,0.001809657,0.00048209008,0.000108828,0.00029065562,0.0016745921,0.9608822,0.0000346415],"about_ca_topic_score_codex":0.0017580229,"about_ca_topic_score_gemma":0.0044878307,"teacher_disagreement_score":0.0050668833,"about_ca_system_score_codex":0.0004241556,"about_ca_system_score_gemma":0.0010204517,"threshold_uncertainty_score":0.016950369},"labels":[],"label_agreement":null},{"id":"W1946581526","doi":"10.1007/s11899-015-0286-x","title":"Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Aurora Research Institute; American Association for Cancer Research","keywords":"Social media; Microblogging; Workflow; Public relations; Internet privacy; Hematologist; Health care; Medicine; Medical education; World Wide Web; Computer science; Internal medicine; Political science","score_opus":0.4678624804527811,"score_gpt":0.5264026431069447,"score_spread":0.05854016265416362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946581526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009287047,0.98858845,0.00006788696,0.0056633875,0.0013050037,0.000012156729,0.00007385263,0.000012560005,0.0033480464],"genre_scores_gemma":[0.008044049,0.984703,0.0002219299,0.002818802,0.002137099,0.00002176049,0.00009904848,0.000005701368,0.0019486179],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994492,0.00019643163,0.00007401748,0.00005989798,0.00016710443,0.00005330679],"domain_scores_gemma":[0.99680746,0.0021747039,0.00049302663,0.00002933558,0.00025824975,0.00023724379],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.00081620086,0.0005627496,0.0007371388,0.002380642,0.0005674363,0.0018874974,0.0005997882,0.0022555992,0.007886132],"category_scores_gemma":[0.00457828,0.00021404056,0.0007226632,0.002133592,0.0005109181,0.0023021048,0.0012793611,0.0018537712,0.0013461616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077055156,0.00008166777,0.0025097323,0.018609015,0.00016052493,0.00027323168,0.00037548298,0.000052900126,0.00023620696,0.0012709684,0.0836203,0.89273286],"study_design_scores_gemma":[0.000039628896,0.0001237006,0.012787888,0.04480821,0.0004911547,0.0017213671,0.0018967544,0.00012230843,0.00026739368,0.0012940294,0.93639255,0.000055069508],"about_ca_topic_score_codex":0.0024591135,"about_ca_topic_score_gemma":0.008529051,"teacher_disagreement_score":0.9981125,"about_ca_system_score_codex":0.0007117568,"about_ca_system_score_gemma":0.0019811068,"threshold_uncertainty_score":0.02638179},"labels":[],"label_agreement":null},{"id":"W2007505304","doi":"10.1007/s11899-014-0213-6","title":"Which Hodgkin’s Patients in the Unites States Should Be Treated with BEACOPP?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Medicine; Procarbazine; Dacarbazine; Vinblastine; Oncology; Internal medicine; Hodgkin's lymphoma; Regimen; Vincristine; Chemotherapy; Cyclophosphamide","score_opus":0.03486173526679406,"score_gpt":0.2923363232740295,"score_spread":0.25747458800723544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007505304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4795096,0.1352569,0.0014804673,0.29168802,0.0037050373,0.00024063588,0.0012588713,0.00014099832,0.08671963],"genre_scores_gemma":[0.8916729,0.063315734,0.002739703,0.032516997,0.0037403437,0.000103179686,0.0009057396,0.00005325315,0.004952205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994592,0.00014398195,0.00008302417,0.000051094616,0.00009764937,0.00016500152],"domain_scores_gemma":[0.9986714,0.00028260748,0.00022684921,0.00003216639,0.0002546983,0.0005324009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075616874,0.00014266142,0.0004267219,0.0007505543,0.001289666,0.0015760012,0.00044755195,0.0013279578,0.006585568],"category_scores_gemma":[0.003425913,0.00020295658,0.00045319155,0.000832499,0.0007381418,0.0019462919,0.00053281453,0.0016275336,0.00068711047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010559699,0.00065252767,0.6770139,0.0005783917,0.00013155845,0.0052877404,0.00086535775,0.00036213524,0.0017477958,0.0025937632,0.06517779,0.24453314],"study_design_scores_gemma":[0.0005575013,0.0008694416,0.7527898,0.005688132,0.00055819633,0.021199511,0.020444445,0.0010122808,0.0020988474,0.008267383,0.18640167,0.00011270941],"about_ca_topic_score_codex":0.013253206,"about_ca_topic_score_gemma":0.042100467,"teacher_disagreement_score":0.013253206,"about_ca_system_score_codex":0.0013244969,"about_ca_system_score_gemma":0.0040306416,"threshold_uncertainty_score":0.026352167},"labels":[],"label_agreement":null},{"id":"W2008576749","doi":"10.1007/s11899-013-0183-0","title":"Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy","year":2013,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Multiple myeloma; Medicine; Bortezomib; Hematology; Internal medicine; Malignancy; Hematologic malignancy; Intensive care medicine; Clinical trial; Oncology","score_opus":0.07505719191943697,"score_gpt":0.3537867960608366,"score_spread":0.2787296041413996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008576749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010744371,0.99782205,0.00020571757,0.0012611299,0.00015939279,0.000004798075,0.000020379795,0.000006280518,0.000412859],"genre_scores_gemma":[0.001036109,0.99731547,0.0005190508,0.0005501924,0.00039437664,0.0000070922556,0.00003802155,0.0000011730809,0.00013842323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950504,0.000096632284,0.00010875182,0.00008300976,0.0001727047,0.00003392539],"domain_scores_gemma":[0.9989491,0.0005550259,0.00019546965,0.000015356121,0.00022550423,0.00005957532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095591677,0.00083554594,0.0030210786,0.0026090778,0.00036007908,0.0016036272,0.0014162954,0.0015345752,0.0016990976],"category_scores_gemma":[0.0024226776,0.0003321996,0.00073797937,0.0022001665,0.0006202757,0.0018902456,0.000775619,0.0027255449,0.0009012213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008548622,0.0000902973,0.0017804095,0.014819903,0.00021596612,0.00037074182,0.000050979066,0.0004742638,0.000666731,0.0031671969,0.03717405,0.94110405],"study_design_scores_gemma":[0.00008859208,0.00016933504,0.0100422995,0.034887835,0.0012376311,0.007929073,0.00046061078,0.0007272976,0.00092311675,0.010775695,0.9326544,0.00010415569],"about_ca_topic_score_codex":0.0024954276,"about_ca_topic_score_gemma":0.0047038584,"teacher_disagreement_score":0.0030210786,"about_ca_system_score_codex":0.001189451,"about_ca_system_score_gemma":0.002428301,"threshold_uncertainty_score":0.0086301565},"labels":[],"label_agreement":null},{"id":"W2014255239","doi":"10.1007/s11899-009-0030-5","title":"Update on the World Health Organization classification of peripheral T-cell lymphomas","year":2009,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoproliferative disorders; Hematology; Medicine; Phenotype; Pathology; Not Otherwise Specified; Oncology; Peripheral T-cell lymphoma; Internal medicine; T cell; Immunology; Biology; Gene; Genetics; Immune system","score_opus":0.07503516850817778,"score_gpt":0.35915129264967016,"score_spread":0.2841161241414924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014255239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002800574,0.9917197,0.000301895,0.0018210149,0.003236358,0.00002049091,0.00026752715,0.000042948395,0.0023099615],"genre_scores_gemma":[0.0010605031,0.9899302,0.001343747,0.0020476372,0.0028657336,0.000019994646,0.00072813587,0.000007775821,0.001996422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933594,0.00010622211,0.00020207824,0.000058716832,0.00024848964,0.000048491514],"domain_scores_gemma":[0.99802434,0.00051755924,0.00037943362,0.00004409677,0.0008737892,0.0001608558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001072059,0.00096190046,0.0022497836,0.007846325,0.0003740143,0.0012631827,0.001442011,0.0010166643,0.0046097273],"category_scores_gemma":[0.0024407778,0.00036660404,0.00096076383,0.005947657,0.0005128703,0.001956271,0.00079976686,0.0016960544,0.0034291984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007749292,0.000057465506,0.0006697317,0.0093931835,0.000104079714,0.00048674835,0.000055909288,0.00015474399,0.00075980625,0.0007829367,0.28525323,0.70220464],"study_design_scores_gemma":[0.000029641338,0.000046552792,0.0022525138,0.00440018,0.00024942865,0.003136637,0.000060801056,0.000058570535,0.00014600724,0.00046254788,0.9891338,0.000023283334],"about_ca_topic_score_codex":0.0045475187,"about_ca_topic_score_gemma":0.0129476655,"teacher_disagreement_score":0.007846325,"about_ca_system_score_codex":0.0012090921,"about_ca_system_score_gemma":0.0030949262,"threshold_uncertainty_score":0.0154210925},"labels":[],"label_agreement":null},{"id":"W2017131345","doi":"10.1007/s11899-012-0139-9","title":"“Antivirals” in the Treatment of Adult T Cell Leukaemia– Lymphoma (ATLL)","year":2012,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Zidovudine; Lymphoma; Oncology; Immunology; Hematology; Virus; Gastroenterology; Viral disease","score_opus":0.06301480317142466,"score_gpt":0.31239457870223897,"score_spread":0.2493797755308143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017131345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015306173,0.99911803,0.000090684785,0.00013448704,0.00012989462,0.0000034024713,0.000011189956,0.0000049040605,0.0003543738],"genre_scores_gemma":[0.0011214429,0.99792176,0.00023105323,0.00023812204,0.0001742673,0.0000056555787,0.00003175796,0.0000011956253,0.00027469723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982446,0.000031450218,0.000039096776,0.00003160844,0.00005560446,0.000017727734],"domain_scores_gemma":[0.99973696,0.00013869848,0.000049564853,0.0000073911206,0.00004592922,0.000021418082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050153676,0.0006798581,0.0013640735,0.001402083,0.0002114581,0.00063692866,0.00088800467,0.0007853568,0.0018162489],"category_scores_gemma":[0.0005821746,0.00022654256,0.0004924874,0.0012858387,0.0004132901,0.00082632026,0.00044429823,0.0017658133,0.0009653805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013109019,0.00007468618,0.00016419594,0.009501751,0.00008900605,0.00018638407,0.000027944938,0.00021173425,0.0016087083,0.0010483579,0.014477934,0.97247833],"study_design_scores_gemma":[0.00013455962,0.0003878573,0.0019168173,0.0052307653,0.00048105052,0.0033008812,0.0000718138,0.00017063077,0.0016048129,0.0015183054,0.9851479,0.00003465827],"about_ca_topic_score_codex":0.0007706728,"about_ca_topic_score_gemma":0.0018534765,"teacher_disagreement_score":0.0018162489,"about_ca_system_score_codex":0.00034591657,"about_ca_system_score_gemma":0.00061206234,"threshold_uncertainty_score":0.0060759187},"labels":[],"label_agreement":null},{"id":"W2022946612","doi":"10.1007/s11899-014-0214-5","title":"Chemotherapy Only in Early Stage Hodgkin Lymphoma: More Relapses but the Same Survival – What to Do?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ABVD; Medicine; Lymphoma; Stage (stratigraphy); Hodgkin's lymphoma; Chemotherapy; Radiation therapy; Hodgkin lymphoma; Internal medicine; Dacarbazine; Randomized controlled trial; Survival rate; Positron emission tomography; Oncology; Surgery; Radiology; Vincristine; Cyclophosphamide","score_opus":0.024286227314749415,"score_gpt":0.3011997911824983,"score_spread":0.2769135638677489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022946612","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12003713,0.553103,0.0013316656,0.3031347,0.012517774,0.00017128634,0.0014637541,0.00019363243,0.008047043],"genre_scores_gemma":[0.4754482,0.3205945,0.0041051186,0.12489621,0.06809547,0.00025941955,0.0022633644,0.00023160013,0.004106199],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963229,0.0014209185,0.0008661264,0.0004700937,0.0005932094,0.00032679318],"domain_scores_gemma":[0.9706194,0.019676974,0.003521551,0.0012170734,0.003124921,0.0018401023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008285268,0.0007216188,0.0049017225,0.00095023605,0.0008898761,0.003976683,0.0022245592,0.004574513,0.00732901],"category_scores_gemma":[0.019841718,0.0005378592,0.001986593,0.0016026755,0.0017384224,0.008163674,0.00086462306,0.0046522515,0.0019936583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007222112,0.0018320162,0.14426038,0.008443178,0.0031898532,0.00089637743,0.0004962833,0.00093559874,0.0024432158,0.0026765263,0.070829056,0.7567753],"study_design_scores_gemma":[0.00882393,0.0149668595,0.6053822,0.025798654,0.019879362,0.010480795,0.009357695,0.0033773554,0.0027237076,0.03187879,0.2663748,0.00095579325],"about_ca_topic_score_codex":0.004276769,"about_ca_topic_score_gemma":0.01059188,"teacher_disagreement_score":0.008285268,"about_ca_system_score_codex":0.0016656988,"about_ca_system_score_gemma":0.0032841489,"threshold_uncertainty_score":0.043817222},"labels":[],"label_agreement":null},{"id":"W2024403341","doi":"10.1007/s11899-013-0163-4","title":"Hodgkin Lymphoma in Pregnancy","year":2013,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Pregnancy; Vinblastine; Lymphoma; Intensive care medicine; Disease; Hodgkin lymphoma; Chemotherapy; Internal medicine; Pediatrics; Obstetrics","score_opus":0.030985646590251492,"score_gpt":0.3045995390588377,"score_spread":0.2736138924685862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024403341","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9078132,0.026557093,0.00050731766,0.006861989,0.00037016819,0.00004676998,0.00031350148,0.00006105076,0.05746878],"genre_scores_gemma":[0.98340803,0.012731105,0.00016054281,0.00057885685,0.00032516665,0.000011808048,0.0001326194,0.000004558499,0.0026473163],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979717,0.000046847967,0.000025483554,0.000020525998,0.000028353363,0.00008164177],"domain_scores_gemma":[0.99959177,0.00013121538,0.00011450367,0.000031295443,0.0000316529,0.00009954069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031073226,0.00013099195,0.00011699283,0.0009664739,0.00056630163,0.00066510873,0.00018574005,0.0005010241,0.0030445145],"category_scores_gemma":[0.0025795568,0.0001623285,0.00009632793,0.0007022972,0.00032017738,0.00050071516,0.00036381008,0.0005406095,0.00046914662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023411201,0.00021340343,0.8508834,0.00010747794,0.000025472875,0.08008247,0.0010546872,0.00016237727,0.0016227015,0.0021486215,0.004157082,0.0593082],"study_design_scores_gemma":[0.000043636963,0.0003241609,0.52478904,0.0006039463,0.00012372612,0.42327973,0.003586223,0.0004845067,0.0023011323,0.002792104,0.041638408,0.00003346266],"about_ca_topic_score_codex":0.0029146662,"about_ca_topic_score_gemma":0.0017957739,"teacher_disagreement_score":0.0030445145,"about_ca_system_score_codex":0.00038984555,"about_ca_system_score_gemma":0.0006919248,"threshold_uncertainty_score":0.010184944},"labels":[],"label_agreement":null},{"id":"W2045989969","doi":"10.1007/s11899-008-0030-x","title":"Novel therapies in peripheral T-cell lymphomas","year":2008,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hematology; Oncology; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Bioinformatics; T cell; Immunology; Biology; Immune system","score_opus":0.07527003511942738,"score_gpt":0.3469950288066572,"score_spread":0.27172499368722985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045989969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121596175,0.99871325,0.00012129135,0.00012507962,0.00017559047,0.0000065202385,0.000013760654,0.000008548218,0.0007144158],"genre_scores_gemma":[0.0007791148,0.9978816,0.00028676708,0.00028377617,0.00020556981,0.000010723488,0.000037875627,0.0000016975262,0.0005128279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981374,0.000034848512,0.0000365888,0.000034605,0.000060159968,0.000020001266],"domain_scores_gemma":[0.99968386,0.00017366488,0.000055805674,0.000010643093,0.00005403901,0.000022065225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064684195,0.00091606315,0.0021136699,0.002001197,0.00024229982,0.0008893052,0.0011099592,0.00090381136,0.003795694],"category_scores_gemma":[0.000710475,0.0003063976,0.00063208357,0.0016599852,0.000434959,0.0012204784,0.00055102794,0.0018457148,0.0020502722],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011839981,0.00010194038,0.0001361224,0.013912465,0.0001129333,0.00026971678,0.000030115849,0.00033695917,0.0014970988,0.00092962384,0.020487363,0.96206725],"study_design_scores_gemma":[0.00014704544,0.00028218387,0.001189307,0.005783947,0.00050831697,0.0026211822,0.000058499616,0.00017378131,0.000842276,0.0011160409,0.98725325,0.00002427628],"about_ca_topic_score_codex":0.00062958995,"about_ca_topic_score_gemma":0.0016361556,"teacher_disagreement_score":0.003795694,"about_ca_system_score_codex":0.00046751075,"about_ca_system_score_gemma":0.0006997455,"threshold_uncertainty_score":0.012697816},"labels":[],"label_agreement":null},{"id":"W2052924000","doi":"10.1007/s11899-007-0022-2","title":"Is BEACOPP better than ABVD?","year":2007,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vincristine; Oncology; Vinblastine; Prednisone; Internal medicine; Cyclophosphamide; Chemotherapy","score_opus":0.14328563488198798,"score_gpt":0.41713827398589703,"score_spread":0.27385263910390906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052924000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007297996,0.9986602,0.000027953662,0.0004623093,0.00024365615,0.000002005339,0.000010379722,0.0000029731368,0.0005175777],"genre_scores_gemma":[0.0007818118,0.9974003,0.000102394304,0.00086332357,0.00047069314,0.0000046893992,0.000026053944,0.0000011280648,0.00034979364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997311,0.00005261975,0.000074394084,0.000049721413,0.00007066811,0.000021495736],"domain_scores_gemma":[0.999445,0.00029585726,0.0001289364,0.000014787433,0.000073333664,0.00004205062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008066641,0.00060663687,0.0021351909,0.0016993118,0.00029235455,0.0011372301,0.00076184544,0.00095238275,0.0050446675],"category_scores_gemma":[0.0016555579,0.00028982022,0.0005579508,0.0018722668,0.00056361116,0.0014988654,0.0004470026,0.001990006,0.0016843685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019134681,0.00004463934,0.00036341936,0.013866585,0.00016698512,0.00023342612,0.000026215124,0.000102310536,0.00038897397,0.0010649083,0.035038367,0.94851285],"study_design_scores_gemma":[0.00017729895,0.00022887147,0.0023594226,0.010647569,0.0008227745,0.0029818958,0.00009378742,0.000058891277,0.00039992784,0.0015272606,0.980678,0.000024389754],"about_ca_topic_score_codex":0.001073903,"about_ca_topic_score_gemma":0.0030681212,"teacher_disagreement_score":0.0050446675,"about_ca_system_score_codex":0.00064103596,"about_ca_system_score_gemma":0.0011948536,"threshold_uncertainty_score":0.016876101},"labels":[],"label_agreement":null},{"id":"W2062299904","doi":"10.1007/s11899-011-0100-3","title":"Update: Peripheral T-Cell Lymphomas","year":2011,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Hematology; Peripheral T-cell lymphoma; Oncology; Internal medicine; Disease; T-cell lymphoma; Peripheral; T cell; Pathology; Immunology; Immune system","score_opus":0.07608571854870042,"score_gpt":0.3457742507995178,"score_spread":0.26968853225081735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062299904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016437976,0.99352854,0.00013887862,0.0010720302,0.003101753,0.000015220406,0.000121340425,0.000035370856,0.0018223731],"genre_scores_gemma":[0.0007791205,0.99152136,0.0003461574,0.0018386974,0.0033446946,0.000014591821,0.00024410183,0.0000052268356,0.0019061441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952126,0.00008133569,0.000131186,0.000053371983,0.00016445342,0.000048449885],"domain_scores_gemma":[0.99849546,0.00049617473,0.00036730155,0.000037443715,0.00044879995,0.00015479162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007827806,0.0012367553,0.0024300606,0.0056696096,0.00032932314,0.0015116774,0.0011725952,0.0013788654,0.00805358],"category_scores_gemma":[0.0023387845,0.00044733737,0.00066546735,0.0048975563,0.00044677424,0.002394881,0.0011248308,0.001784146,0.0042939917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010476946,0.00005607365,0.000413601,0.01833121,0.00013566816,0.0005234973,0.000037286234,0.00023224225,0.0008836473,0.00031373027,0.2810019,0.6979665],"study_design_scores_gemma":[0.00004181209,0.00008494557,0.0014040127,0.006913182,0.00049702363,0.0033062147,0.000054156208,0.00007050648,0.00022905991,0.0002980592,0.9870781,0.000022921058],"about_ca_topic_score_codex":0.0015462951,"about_ca_topic_score_gemma":0.0054672207,"teacher_disagreement_score":0.00805358,"about_ca_system_score_codex":0.0008136259,"about_ca_system_score_gemma":0.0019880892,"threshold_uncertainty_score":0.026941895},"labels":[],"label_agreement":null},{"id":"W2191051211","doi":"10.1007/s11899-015-0296-8","title":"Myelofibrosis—When Do We Select Transplantation or Non-transplantation Therapeutic Options?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Transplantation; Ruxolitinib; Hematology; Internal medicine; Hematopoietic stem cell transplantation; Janus kinase; Oncology; Intensive care medicine; Disease; Bone marrow","score_opus":0.11694056028219584,"score_gpt":0.39379647031905823,"score_spread":0.2768559100368624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191051211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002898827,0.99578613,0.00017250293,0.002241852,0.00040828038,0.0000037656946,0.000025762827,0.0000071804766,0.0010646584],"genre_scores_gemma":[0.003910822,0.9912486,0.00064625713,0.0022676447,0.0014564664,0.000009746021,0.00006561706,0.0000031072539,0.00039172644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997116,0.000068792295,0.000084691936,0.000043658165,0.00007071176,0.0000205537],"domain_scores_gemma":[0.99866617,0.00078776747,0.00025533195,0.000020371997,0.00018957297,0.000080791026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081482384,0.00044806395,0.0014075655,0.0018253764,0.0002741725,0.0013970467,0.00066884,0.0009232171,0.0030271958],"category_scores_gemma":[0.0035548392,0.00018272238,0.0004570305,0.0012679476,0.0006073218,0.001893114,0.00046260995,0.0017545369,0.00078279106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083304745,0.000040586445,0.0016993122,0.009296516,0.00014825954,0.00049345015,0.00007437922,0.00023947339,0.00032871717,0.0029324165,0.04487551,0.93978804],"study_design_scores_gemma":[0.00009864736,0.00012350729,0.0045746337,0.03792348,0.0009773105,0.009450073,0.00048158196,0.0002460744,0.00038711628,0.0065185637,0.9391658,0.000053295284],"about_ca_topic_score_codex":0.00091213343,"about_ca_topic_score_gemma":0.0030378844,"teacher_disagreement_score":0.0030271958,"about_ca_system_score_codex":0.0005221116,"about_ca_system_score_gemma":0.0014126498,"threshold_uncertainty_score":0.010127008},"labels":[],"label_agreement":null},{"id":"W2287622513","doi":"10.1007/s11899-016-0313-6","title":"Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"National Cancer Institute","keywords":"Medicine; Young adult; Cancer; Breast cancer; Incidence (geometry); Population; Social media; Oncology; Internal medicine; Pediatrics; Gerontology","score_opus":0.05691916317588371,"score_gpt":0.35652611882657814,"score_spread":0.29960695565069445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287622513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017758434,0.99673635,0.000012133147,0.00041493814,0.00011980914,0.00000413032,0.00003969994,0.0000012879178,0.00089577725],"genre_scores_gemma":[0.009166468,0.9900934,0.00004711582,0.00027394216,0.00014902958,0.0000059563467,0.00003533533,4.3898638e-7,0.0002283128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998172,0.00005018553,0.000033866992,0.000025352583,0.000053920754,0.000019625402],"domain_scores_gemma":[0.9992192,0.0004829758,0.0001938328,0.000005966868,0.000049761682,0.00004831631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029622047,0.0003039507,0.0005651275,0.001415599,0.000323558,0.0010221578,0.00030039603,0.00070086407,0.0022473435],"category_scores_gemma":[0.0015175664,0.00014209883,0.00058217515,0.001704075,0.0002708234,0.0007886915,0.0005229942,0.00082752696,0.0001977855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015553818,0.00018367295,0.024242321,0.049325816,0.00088906736,0.0009689999,0.0006854595,0.0001176698,0.00034203017,0.0014958795,0.018599378,0.9029943],"study_design_scores_gemma":[0.00008148176,0.00030157584,0.110969886,0.098709226,0.003964941,0.0094473725,0.0041864053,0.00014500573,0.0005292104,0.0014085118,0.7701572,0.00009912523],"about_ca_topic_score_codex":0.0033669823,"about_ca_topic_score_gemma":0.010024917,"teacher_disagreement_score":0.0033669823,"about_ca_system_score_codex":0.00037924427,"about_ca_system_score_gemma":0.000938474,"threshold_uncertainty_score":0.007518053},"labels":[],"label_agreement":null},{"id":"W2309364123","doi":"10.1007/s11899-016-0317-2","title":"Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Hematology; Chemotherapy; Hematopoietic cell; Transplantation; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Lymphoblastic Leukemia; Young adult; Acute lymphocytic leukemia; Leukemia; Intensive care medicine; Pediatrics; Haematopoiesis; Stem cell","score_opus":0.03268983140793776,"score_gpt":0.3511645003849713,"score_spread":0.3184746689770336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309364123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012782682,0.99910873,0.000034219207,0.00013339595,0.000103651655,0.000002896566,0.000014012549,0.0000026752832,0.0004727038],"genre_scores_gemma":[0.0010724061,0.99826545,0.00008640163,0.00025622678,0.00014424429,0.0000032543576,0.000027400873,7.4299254e-7,0.00014404551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998111,0.000035205478,0.000055851593,0.00003132802,0.000054128057,0.000012423905],"domain_scores_gemma":[0.9995327,0.00028418147,0.00010469448,0.000009519898,0.000044172513,0.000024629051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004569013,0.00041550427,0.00085447344,0.001713797,0.0001679369,0.00071088853,0.0005245088,0.00048480957,0.0026356268],"category_scores_gemma":[0.0013628178,0.00014781606,0.0004238458,0.0017557767,0.0003080736,0.0007695397,0.00047544125,0.00093053066,0.00051945064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090561465,0.000038902373,0.0007898275,0.024508106,0.0001494639,0.00026548488,0.00004477089,0.00012665086,0.000558406,0.00085752713,0.018740313,0.95382994],"study_design_scores_gemma":[0.00012234526,0.00017637688,0.004426843,0.026360491,0.001417656,0.005655874,0.00015860761,0.00008272706,0.0007056533,0.0014387632,0.95942676,0.00002784934],"about_ca_topic_score_codex":0.0008060886,"about_ca_topic_score_gemma":0.0019292937,"teacher_disagreement_score":0.0026356268,"about_ca_system_score_codex":0.00033098724,"about_ca_system_score_gemma":0.0010194387,"threshold_uncertainty_score":0.008817077},"labels":[],"label_agreement":null},{"id":"W2409124043","doi":"10.1007/s11899-016-0333-2","title":"Value Based Care and Patient-Centered Care: Divergent or Complementary?","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Value (mathematics); Health care; Quality (philosophy); Incentive; Medicine; Preference; Payment; Value-Based Purchasing; Reimbursement; Nursing; Family medicine; Business; Computer science; Economics; Microeconomics","score_opus":0.09273398251352287,"score_gpt":0.31652480232982744,"score_spread":0.22379081981630455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409124043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023254505,0.99032813,0.00020609936,0.0075112367,0.00030223277,0.0000033205997,0.000010681555,0.0000017695041,0.0014040386],"genre_scores_gemma":[0.008347718,0.9858504,0.00042066508,0.0038401003,0.0012500118,0.000012928236,0.000019220442,0.000003502266,0.0002554337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665534,0.0015674151,0.00030762414,0.00029208185,0.0009741207,0.00020346855],"domain_scores_gemma":[0.9819449,0.014124309,0.0016394191,0.00030012167,0.00152,0.00047126986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00781749,0.00066263584,0.0025461135,0.0023878135,0.0004992328,0.0059350096,0.001790218,0.0034665042,0.006503638],"category_scores_gemma":[0.015229593,0.0003533921,0.00095308444,0.0061081448,0.0050338684,0.005502454,0.00228521,0.0050005526,0.00076606165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000152602,0.00012930406,0.0016390997,0.022659244,0.0005177996,0.00011956959,0.00072174094,0.00051296665,0.00011150364,0.14251567,0.02707866,0.8038418],"study_design_scores_gemma":[0.00016044242,0.00018236216,0.0083630495,0.081334226,0.00065789605,0.001000787,0.0030834542,0.00053950865,0.00017598984,0.16641541,0.737973,0.00011386493],"about_ca_topic_score_codex":0.004945904,"about_ca_topic_score_gemma":0.008641502,"teacher_disagreement_score":0.00781749,"about_ca_system_score_codex":0.003706068,"about_ca_system_score_gemma":0.007837328,"threshold_uncertainty_score":0.04134333},"labels":[],"label_agreement":null},{"id":"W2482129219","doi":"10.1007/s11899-016-0340-3","title":"Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; European Hematology Association","keywords":"Social media; Hematology; The Internet; Hematologic malignancy; Medicine; Cancer; Internal medicine; Family medicine; Computer science; World Wide Web","score_opus":0.04298612721636083,"score_gpt":0.33799098968274327,"score_spread":0.29500486246638247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482129219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041397284,0.99324185,0.0000650738,0.0005913862,0.00014495321,0.00001681523,0.00011400742,0.000007014732,0.001679188],"genre_scores_gemma":[0.032544654,0.9645282,0.00034651172,0.0010353645,0.0003763251,0.00004231389,0.00023043793,0.0000025918891,0.00089359184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998716,0.000037043646,0.000026343088,0.0000194007,0.00003146169,0.000014114418],"domain_scores_gemma":[0.99958915,0.00025604144,0.00009349985,0.0000064786673,0.000029555176,0.000025298741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022695074,0.00025868576,0.00061905937,0.0012517858,0.00023470375,0.00052932557,0.00034447468,0.00050497934,0.0033833233],"category_scores_gemma":[0.0010547648,0.00010401596,0.00068839313,0.001053046,0.00015861822,0.0006430096,0.00041756468,0.0005616305,0.00032669795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025606886,0.00016734844,0.00885077,0.02075797,0.00043965128,0.0005854564,0.00014197125,0.000063943015,0.0005765397,0.00039778108,0.015123108,0.9526394],"study_design_scores_gemma":[0.0005099403,0.0010637722,0.10114054,0.06163138,0.0072709857,0.016957093,0.0018082396,0.00047056464,0.0018145707,0.0017513693,0.8054568,0.00012480844],"about_ca_topic_score_codex":0.0013786684,"about_ca_topic_score_gemma":0.0039947517,"teacher_disagreement_score":0.0033833233,"about_ca_system_score_codex":0.00021065396,"about_ca_system_score_gemma":0.00044287785,"threshold_uncertainty_score":0.011318266},"labels":[],"label_agreement":null},{"id":"W2483061118","doi":"10.1007/s11899-016-0341-2","title":"Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM","year":2016,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AOP Orphan","keywords":"Social media; Hematologic Neoplasms; Social media analytics; Myeloproliferative neoplasm; Health care; Medicine; Public relations; Interpersonal communication; Internet privacy; Internal medicine; Political science; World Wide Web; Computer science; Sociology; Myelofibrosis; Social science; Cancer","score_opus":0.06264256132008802,"score_gpt":0.3193700999007866,"score_spread":0.2567275385806985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483061118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658153,0.00095153233,0.00048961747,0.00082246703,0.00013782225,0.000086915614,0.02615362,0.00014560457,0.005397138],"genre_scores_gemma":[0.9754284,0.00052790326,0.0011871611,0.00011900153,0.00031064448,0.000112745125,0.01969111,0.000041096737,0.0025820185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987413,0.00027680784,0.00017717406,0.00013911606,0.0004967325,0.00016885073],"domain_scores_gemma":[0.9880734,0.0028368812,0.0049333344,0.00038402842,0.00224286,0.0015295013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010478137,0.00039338728,0.00034414328,0.0044851303,0.0005356215,0.0015915206,0.0004191036,0.00069231633,0.0026298035],"category_scores_gemma":[0.008709104,0.00011294623,0.0004584003,0.0039295945,0.00024044495,0.0020879891,0.0012625993,0.0005774395,0.0014315819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117987016,0.00006802753,0.97272915,0.00011117774,0.000110580084,0.00007940242,0.00037504887,0.00021438288,0.00036329599,0.00016876185,0.0045485315,0.02111368],"study_design_scores_gemma":[0.0000033448907,0.000114445225,0.9894565,0.000037860293,0.000049251725,0.00033785566,0.0012317764,0.0019275963,0.00027698666,0.00011937841,0.0064256797,0.000019349633],"about_ca_topic_score_codex":0.005274445,"about_ca_topic_score_gemma":0.009917025,"teacher_disagreement_score":0.005274445,"about_ca_system_score_codex":0.00046863375,"about_ca_system_score_gemma":0.00040473702,"threshold_uncertainty_score":0.010487497},"labels":[],"label_agreement":null},{"id":"W2593332867","doi":"10.1007/s11899-017-0372-3","title":"New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ponatinib; Medicine; Blinatumomab; Internal medicine; Oncology; Philadelphia chromosome; Dasatinib; Imatinib; Hematology; Chemotherapy; Lymphoblastic Leukemia; Leukemia; Chromosomal translocation; Myeloid leukemia","score_opus":0.11414245544969435,"score_gpt":0.400997813282527,"score_spread":0.2868553578328326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593332867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009189591,0.9987565,0.00008955441,0.00024326888,0.00014587888,0.0000047296453,0.00002167965,0.0000051592488,0.00064122316],"genre_scores_gemma":[0.0008270991,0.9980732,0.0001921555,0.0004145517,0.00015415484,0.0000070357914,0.00004500736,0.0000014090704,0.0002853976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998385,0.000032475105,0.00003757365,0.000029375376,0.000046453097,0.00001561335],"domain_scores_gemma":[0.999708,0.00017094839,0.00005394624,0.0000068346035,0.000044993118,0.000015195991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043479068,0.0005521362,0.001176436,0.0014709893,0.00022216309,0.00076420134,0.00080382277,0.0006643318,0.0044364724],"category_scores_gemma":[0.0010334064,0.000213567,0.00067998964,0.0011459871,0.00030835863,0.0010617069,0.0005193871,0.0015517671,0.00097591657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008396575,0.000058299876,0.0002341033,0.019267052,0.0001272295,0.00014276463,0.000035003068,0.0002788,0.0006759193,0.0020755716,0.026217664,0.9508037],"study_design_scores_gemma":[0.00008623094,0.00017314404,0.0012090827,0.010462248,0.0006517491,0.0016349554,0.00007823969,0.0001482814,0.00047297138,0.0022642538,0.9827947,0.000024082026],"about_ca_topic_score_codex":0.00085674843,"about_ca_topic_score_gemma":0.002280351,"teacher_disagreement_score":0.0044364724,"about_ca_system_score_codex":0.00039288806,"about_ca_system_score_gemma":0.000781912,"threshold_uncertainty_score":0.014841437},"labels":[],"label_agreement":null},{"id":"W2595388903","doi":"10.1007/s11899-017-0368-z","title":"Current Review on High-Risk Multiple Myeloma","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Risk stratification; Disease; Intensive care medicine; Hematology; Internal medicine; Oncology; Risk assessment","score_opus":0.1741396546027891,"score_gpt":0.4409754810943322,"score_spread":0.26683582649154314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595388903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006483823,0.99876827,0.00004694364,0.00025330516,0.00022049759,0.0000055209807,0.0000428398,0.000005260591,0.00059249904],"genre_scores_gemma":[0.00044560197,0.99856585,0.00012706548,0.0003417238,0.0002694143,0.000005243893,0.000050884122,9.227483e-7,0.00019335523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996438,0.00006278968,0.00011432347,0.000056046,0.00009954244,0.000023592656],"domain_scores_gemma":[0.9990569,0.00053174817,0.0002052807,0.000015682743,0.0001458308,0.000044612116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051156135,0.00068148377,0.0015641698,0.0031468857,0.0002636324,0.0013912646,0.00074421405,0.0009709081,0.006961814],"category_scores_gemma":[0.0023527495,0.00028770807,0.0009170718,0.0035980565,0.00031843095,0.0013582284,0.00079371314,0.0012340371,0.0011855819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117160336,0.000061541235,0.00071469636,0.091534525,0.00043666517,0.0002515567,0.00010313188,0.00021540126,0.00051142706,0.0015479412,0.066328384,0.83817744],"study_design_scores_gemma":[0.000051520667,0.00008104905,0.0021767789,0.033357386,0.0014274983,0.0017829841,0.0001230023,0.00007949545,0.00019883331,0.0014694884,0.95921755,0.00003441889],"about_ca_topic_score_codex":0.0014288558,"about_ca_topic_score_gemma":0.0031133387,"teacher_disagreement_score":0.006961814,"about_ca_system_score_codex":0.00051174086,"about_ca_system_score_gemma":0.0020829898,"threshold_uncertainty_score":0.02328962},"labels":[],"label_agreement":null},{"id":"W2766413477","doi":"10.1007/s11899-017-0421-y","title":"Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Social media; Social media analytics; Internet privacy; Field (mathematics); Health care; Categorization; Order (exchange); Analytics; Public relations; Medicine; Computer science; World Wide Web; Data science; Political science; Business","score_opus":0.41426121650310205,"score_gpt":0.48448902755134826,"score_spread":0.07022781104824621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766413477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09227587,0.88200384,0.0010707248,0.0033319262,0.0008588084,0.00018670736,0.014889485,0.000067171204,0.0053154714],"genre_scores_gemma":[0.2877806,0.69170374,0.0037675838,0.0015276748,0.0015684491,0.0003676491,0.01062092,0.000038574188,0.0026247576],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991541,0.00018865771,0.00019700878,0.00013407912,0.00025559586,0.00007052131],"domain_scores_gemma":[0.9963599,0.0014911534,0.0013519814,0.000068845155,0.00053866906,0.00018939635],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.001242421,0.000638946,0.00080338167,0.0047446005,0.00029915763,0.0012915325,0.0005819599,0.0007668019,0.0021028705],"category_scores_gemma":[0.005644252,0.00018123501,0.0017017663,0.005830207,0.00021095526,0.0017512651,0.0010174386,0.0007864093,0.000487236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035699125,0.00012652433,0.25411165,0.02853648,0.0025674573,0.00032456662,0.0014189674,0.00041202098,0.000625441,0.0014218894,0.025494216,0.6846038],"study_design_scores_gemma":[0.000065542576,0.00041882868,0.68117964,0.032465138,0.006022279,0.0025430564,0.0046693385,0.001651386,0.0010808283,0.0017111587,0.2679838,0.00020899047],"about_ca_topic_score_codex":0.0048929825,"about_ca_topic_score_gemma":0.01498209,"teacher_disagreement_score":0.9952554,"about_ca_system_score_codex":0.0005830939,"about_ca_system_score_gemma":0.0012599635,"threshold_uncertainty_score":0.009728968},"labels":[],"label_agreement":null},{"id":"W2766799159","doi":"10.1007/s11899-017-0424-8","title":"Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dystopia; Hematology; Utopia; Internal medicine; Social media; Medicine; Political science; Law","score_opus":0.5896881544385401,"score_gpt":0.5592891715628737,"score_spread":0.030398982875666336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766799159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021364143,0.9979779,0.000022962702,0.00097610196,0.0002469981,0.000004610269,0.000028902308,0.0000025117813,0.00052629295],"genre_scores_gemma":[0.0020772428,0.9966732,0.000064073436,0.0005819131,0.00037525457,0.0000065732443,0.00002587103,0.0000011392386,0.00019478341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99946123,0.00016669165,0.00010032139,0.000062974046,0.00015606098,0.000052745505],"domain_scores_gemma":[0.99768186,0.0016833905,0.0003104746,0.000024217343,0.00019620961,0.00010371033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010691198,0.000599565,0.001166319,0.0034082702,0.00046686054,0.0019027911,0.00059841375,0.0014885992,0.0048862216],"category_scores_gemma":[0.0034710206,0.00021216899,0.00094860455,0.0033864037,0.00073204696,0.00233769,0.0011134094,0.0016333953,0.0006082573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009436255,0.000050507766,0.0016497561,0.048056565,0.00029860847,0.00016819168,0.00031193395,0.00007523166,0.00021072819,0.0037469005,0.027890678,0.9174465],"study_design_scores_gemma":[0.00006322414,0.00012154204,0.0087898215,0.1141709,0.0013251238,0.0021835852,0.0015898173,0.000113593975,0.00033291487,0.0035360972,0.867713,0.000060325685],"about_ca_topic_score_codex":0.0023787098,"about_ca_topic_score_gemma":0.0068190605,"teacher_disagreement_score":0.0048862216,"about_ca_system_score_codex":0.00078053965,"about_ca_system_score_gemma":0.0023848827,"threshold_uncertainty_score":0.016345978},"labels":[],"label_agreement":null},{"id":"W2767073213","doi":"10.1007/s11899-017-0422-x","title":"Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Context (archaeology); Medicine; Disease; Cancer; Family medicine; Internal medicine; Computer science; World Wide Web; Biology","score_opus":0.4136773431322619,"score_gpt":0.47976849415244993,"score_spread":0.06609115102018803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767073213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32088235,0.59595484,0.0035632066,0.0050927238,0.0017245327,0.00037502125,0.056707833,0.0002703687,0.015429119],"genre_scores_gemma":[0.6972977,0.26076886,0.0057016183,0.0013161583,0.001797831,0.0004938202,0.027285572,0.00006271631,0.005275723],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994253,0.00011773433,0.00012288403,0.0001105126,0.00017032569,0.000053257547],"domain_scores_gemma":[0.99767727,0.00091896165,0.0007322522,0.000059785572,0.00048818253,0.00012353505],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.00088450266,0.00055592856,0.0006201078,0.0044204136,0.00028377972,0.0010214642,0.00043908219,0.00060624065,0.0022518376],"category_scores_gemma":[0.003916635,0.00013586832,0.001050691,0.0047997497,0.00014595565,0.0013323227,0.00074174337,0.0004659791,0.0006171506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050245225,0.00013080258,0.32257462,0.023535565,0.0025877026,0.00037537035,0.0015075881,0.0007559751,0.0017397278,0.0017636553,0.039159816,0.6053667],"study_design_scores_gemma":[0.000064061285,0.00046490738,0.73811495,0.010855702,0.0053378246,0.0024454664,0.004119134,0.0040216045,0.0021879124,0.002117899,0.2300558,0.00021473577],"about_ca_topic_score_codex":0.0032631177,"about_ca_topic_score_gemma":0.009815395,"teacher_disagreement_score":0.9955796,"about_ca_system_score_codex":0.00035755357,"about_ca_system_score_gemma":0.0007263702,"threshold_uncertainty_score":0.007533133},"labels":[],"label_agreement":null},{"id":"W2801721440","doi":"10.1007/s11899-018-0449-7","title":"Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Imatinib; Oncology; Disease; Tyrosine kinase; Imatinib mesylate; Tyrosine-kinase inhibitor; Internal medicine; Myeloid leukemia; Toxicity; Pharmacology; Intensive care medicine; Cancer","score_opus":0.07998761122677826,"score_gpt":0.4216340902875697,"score_spread":0.34164647906079143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801721440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052088624,0.99888307,0.00006632043,0.0005316714,0.00011439488,0.0000024916276,0.000011008001,0.0000023955897,0.0003365459],"genre_scores_gemma":[0.0006476267,0.9985134,0.00016345666,0.0003500698,0.00018389181,0.0000037359832,0.00001805526,5.8035556e-7,0.00011917292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997017,0.00008765691,0.000057510828,0.00004109329,0.00009003755,0.000021838225],"domain_scores_gemma":[0.9987999,0.00086103525,0.00015299112,0.000014482165,0.00012902178,0.000042472515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096082233,0.000551753,0.0012678873,0.00134728,0.00020025486,0.0011642566,0.0009473969,0.0009885945,0.003994262],"category_scores_gemma":[0.0019503041,0.00018513745,0.0007407138,0.0013531124,0.00039881808,0.0013751319,0.00056915765,0.0019054817,0.00076621724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011260275,0.000054201664,0.00020100601,0.020245617,0.00017789593,0.0001096099,0.000038992224,0.00040239774,0.00036010996,0.003752015,0.028861074,0.9456845],"study_design_scores_gemma":[0.00009157696,0.0001380269,0.0011693,0.025696637,0.0006754977,0.0011036961,0.000116797426,0.0002842879,0.0002461656,0.0046289605,0.9658188,0.000030296493],"about_ca_topic_score_codex":0.0009878239,"about_ca_topic_score_gemma":0.0026868787,"teacher_disagreement_score":0.003994262,"about_ca_system_score_codex":0.00064145646,"about_ca_system_score_gemma":0.0013668955,"threshold_uncertainty_score":0.01336211},"labels":[],"label_agreement":null},{"id":"W2895867440","doi":"10.1007/s11899-018-0490-6","title":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN—Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Disease; Medicine; Health care; Order (exchange); Political science; Internal medicine; Computer science; Business; World Wide Web","score_opus":0.09026787319341162,"score_gpt":0.34961401856504704,"score_spread":0.2593461453716354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895867440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004574505,0.99112225,0.00012852986,0.000784023,0.0002781145,0.000017378112,0.0005024475,0.000012110468,0.0025806471],"genre_scores_gemma":[0.020477537,0.9767397,0.00027560806,0.00073416776,0.0002773623,0.000016960761,0.0005524073,0.000003809969,0.0009223667],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997793,0.000041736017,0.000047719514,0.000045413155,0.000059350186,0.000026554137],"domain_scores_gemma":[0.9994074,0.00028926003,0.00017476677,0.000011998714,0.00008342249,0.000033208496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003178168,0.00027637757,0.00041701613,0.0015901672,0.00022995158,0.0007997174,0.00031141908,0.0005388953,0.0028979848],"category_scores_gemma":[0.0012484334,0.00011422385,0.00045464278,0.0018747072,0.00022126593,0.0008955922,0.00047930863,0.0005751594,0.0005655918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011659491,0.000041569547,0.02378598,0.024867516,0.00034883549,0.0006041606,0.00040695895,0.000106161075,0.0008503077,0.001322343,0.024530113,0.9230194],"study_design_scores_gemma":[0.00002607666,0.00012654754,0.06770856,0.028284065,0.0012892182,0.009863672,0.0015176563,0.00011963172,0.0009773498,0.000991736,0.8890361,0.00005937706],"about_ca_topic_score_codex":0.0029602833,"about_ca_topic_score_gemma":0.008112376,"teacher_disagreement_score":0.0029602833,"about_ca_system_score_codex":0.000302758,"about_ca_system_score_gemma":0.0007657252,"threshold_uncertainty_score":0.0096946955},"labels":[],"label_agreement":null},{"id":"W2913763056","doi":"10.1007/s11899-019-0498-6","title":"Industry’s Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy","year":2019,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"NIH Clinical Center; Novartis Pharmaceuticals Corporation; University of Pennsylvania","keywords":"Chimeric antigen receptor; Medicine; Immunotherapy; Hematology; Cytokine release syndrome; Internal medicine; Clinical trial; Oncology; Cancer","score_opus":0.09754620024724776,"score_gpt":0.37582670228071946,"score_spread":0.2782805020334717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913763056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010327539,0.9978173,0.00013157816,0.0005760335,0.00043407106,0.0000047544477,0.000013967157,0.000008661808,0.000910276],"genre_scores_gemma":[0.0010608342,0.9972542,0.00017850654,0.000647438,0.00027579846,0.000007316799,0.000024691419,0.0000025725074,0.0005485247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996026,0.00009018898,0.000044705583,0.000060769617,0.00015667363,0.000045018718],"domain_scores_gemma":[0.9994006,0.0003099338,0.00007611976,0.000016920898,0.00015712627,0.000039296705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009058719,0.00060908234,0.0009170316,0.0018790318,0.00023740677,0.001210035,0.0005870937,0.0012240182,0.0037220994],"category_scores_gemma":[0.0013193872,0.00021062544,0.0006642105,0.0016111034,0.00047498578,0.00145928,0.0007112083,0.00207705,0.0017794736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008290498,0.00005304264,0.00013614405,0.03239457,0.00011869532,0.00020523937,0.0000908441,0.00047998747,0.0028596083,0.009821719,0.055732705,0.89802456],"study_design_scores_gemma":[0.000013019042,0.000058598744,0.00021051723,0.0038161215,0.00008614944,0.000449374,0.00004335718,0.000055407945,0.0005714915,0.0014165461,0.9932702,0.000009231742],"about_ca_topic_score_codex":0.00092534075,"about_ca_topic_score_gemma":0.0012454257,"teacher_disagreement_score":0.0037220994,"about_ca_system_score_codex":0.000645876,"about_ca_system_score_gemma":0.0017114711,"threshold_uncertainty_score":0.012451649},"labels":[],"label_agreement":null},{"id":"W3008063389","doi":"10.1007/s11899-020-00560-x","title":"Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia","year":2020,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Chronic myelogenous leukemia; Medicine; Tyrosine kinase; Hematology; Dasatinib; Toxicity; Internal medicine; Tyrosine-kinase inhibitor; breakpoint cluster region; Imatinib; Leukemia; Cancer research; Pharmacology; Oncology; Receptor; Myeloid leukemia; Cancer","score_opus":0.04617367194453772,"score_gpt":0.3129403496724175,"score_spread":0.2667666777278798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008063389","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010002061,0.9991872,0.00003765403,0.00013589537,0.00013647684,0.000004221745,0.00001668152,0.000003500824,0.0003784707],"genre_scores_gemma":[0.00047028632,0.9990632,0.000048667323,0.00011779127,0.00011640407,0.0000031726938,0.000016713173,5.4480336e-7,0.0001632042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984753,0.000029126533,0.00003385956,0.000021903112,0.00005642111,0.000011174113],"domain_scores_gemma":[0.999652,0.000167066,0.00008666021,0.0000056949616,0.000068797905,0.000019763973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036902158,0.0006099388,0.0010850856,0.001743865,0.0001814821,0.00073651626,0.0005546433,0.0005958146,0.0031865477],"category_scores_gemma":[0.000885251,0.0001545693,0.00048086364,0.0015238698,0.00023545865,0.0007566812,0.0004320897,0.00079380436,0.00081511046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009174694,0.000042137734,0.00026510112,0.06672481,0.00020142879,0.00022693253,0.000078091725,0.00031790067,0.0012204958,0.0019923658,0.032514803,0.89632416],"study_design_scores_gemma":[0.000028813787,0.00017193009,0.0018201083,0.019445572,0.0004896774,0.0021446147,0.00010522181,0.00009719471,0.00052964914,0.0015070144,0.97363764,0.000022335624],"about_ca_topic_score_codex":0.00073120784,"about_ca_topic_score_gemma":0.0012119348,"teacher_disagreement_score":0.0031865477,"about_ca_system_score_codex":0.00034895938,"about_ca_system_score_gemma":0.0010467885,"threshold_uncertainty_score":0.010660112},"labels":[],"label_agreement":null},{"id":"W4282946191","doi":"10.1007/s11899-022-00663-7","title":"Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Canadian Institutes of Health Research","keywords":"CHEK2; Germline; Myeloid leukemia; Myeloid; Germline mutation; Biology; Chronic lymphocytic leukemia; Leukemia; Cancer research; Immunology; Genetics; Mutation; Gene","score_opus":0.0919673839579153,"score_gpt":0.37176420474396765,"score_spread":0.27979682078605234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032184614,0.99808806,0.00012988602,0.00025971245,0.00018073882,0.0000028614559,0.00004149463,0.000008366671,0.00096700777],"genre_scores_gemma":[0.0026308065,0.99584657,0.00023465537,0.00033615922,0.00027709713,0.0000032916266,0.000101077654,0.0000017358363,0.0005686304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984777,0.000019181789,0.00003230798,0.000040262108,0.000047061476,0.000013356981],"domain_scores_gemma":[0.9997187,0.00015321016,0.00005458137,0.0000071089803,0.00004684514,0.000019508823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031587208,0.00047346015,0.00075593777,0.00208251,0.00013140478,0.00060860877,0.0005402265,0.00052517944,0.0030283302],"category_scores_gemma":[0.0008927831,0.00015995813,0.00036758764,0.0019075078,0.00027232306,0.00065030594,0.00043507674,0.0007495529,0.00070177234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008329175,0.0000218352,0.0012179997,0.010188544,0.0001688645,0.00067837624,0.000035166788,0.00021513485,0.0013400406,0.0010460076,0.027389497,0.95761514],"study_design_scores_gemma":[0.00005770164,0.00009185344,0.005773616,0.009134565,0.0013109396,0.011572422,0.00010930921,0.0001489297,0.0010920127,0.0017065068,0.96896565,0.000036489277],"about_ca_topic_score_codex":0.0010251098,"about_ca_topic_score_gemma":0.0017995635,"teacher_disagreement_score":0.0030283302,"about_ca_system_score_codex":0.00031615948,"about_ca_system_score_gemma":0.00081108604,"threshold_uncertainty_score":0.010130763},"labels":[],"label_agreement":null},{"id":"W4309706624","doi":"10.1007/s11899-022-00682-4","title":"The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Oncology; Nausea; Internal medicine; Vomiting","score_opus":0.07597734830097738,"score_gpt":0.36046075590868615,"score_spread":0.28448340760770874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309706624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081920254,0.9995043,0.000025924706,0.000105355044,0.000057300436,0.000002213476,0.000011295506,0.00000197191,0.00020960448],"genre_scores_gemma":[0.0006559629,0.9988906,0.000081903694,0.00013114198,0.00006453653,0.0000031009392,0.000021308328,4.9658286e-7,0.0001510267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982554,0.000035761423,0.000039909894,0.000024564008,0.00005876952,0.000015443722],"domain_scores_gemma":[0.999681,0.00016405922,0.00007264341,0.000006320774,0.000056774617,0.000019171715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000636932,0.0005721519,0.0014832288,0.0018420658,0.00018225188,0.0009340495,0.0007789929,0.0007120384,0.0027385356],"category_scores_gemma":[0.0008718349,0.00023397112,0.0008135154,0.0017956849,0.0002751487,0.0009562574,0.00048623362,0.001331074,0.0006820688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002634963,0.0000640693,0.000249946,0.031308424,0.00042085914,0.00015141192,0.000040954994,0.00031416665,0.0009909475,0.0014958394,0.01753145,0.9471686],"study_design_scores_gemma":[0.00023305262,0.000327828,0.0020424477,0.0118312305,0.0014577742,0.001420792,0.00007920064,0.00022645459,0.0006991512,0.0014764947,0.9801713,0.000034222412],"about_ca_topic_score_codex":0.0012889415,"about_ca_topic_score_gemma":0.002910509,"teacher_disagreement_score":0.0027385356,"about_ca_system_score_codex":0.0004449859,"about_ca_system_score_gemma":0.0010289012,"threshold_uncertainty_score":0.0091612935},"labels":[],"label_agreement":null},{"id":"W4376641118","doi":"10.1007/s11899-023-00698-4","title":"A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment","year":2023,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Hematology; Oncology; Internal medicine; Population; Intensive care medicine","score_opus":0.0647491682968343,"score_gpt":0.36325252237516004,"score_spread":0.29850335407832573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376641118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009071747,0.9980599,0.00016395071,0.0006532699,0.00016992357,0.0000146102875,0.000016565526,0.000005832431,0.000825159],"genre_scores_gemma":[0.0018888367,0.9951355,0.0008184765,0.00147515,0.0002762533,0.000023307795,0.000032155374,0.000001594548,0.00034888805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924785,0.00027600062,0.00017675884,0.000068101064,0.00019910275,0.00003218858],"domain_scores_gemma":[0.9985129,0.0010414846,0.00023002956,0.000019723331,0.00015653805,0.00003922546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016515055,0.00061560003,0.0016691412,0.001554905,0.0002485081,0.001365753,0.00087697885,0.001168729,0.004064015],"category_scores_gemma":[0.0033129847,0.00023138375,0.0013383159,0.0010338662,0.00039406965,0.0010265998,0.0006373361,0.0023189995,0.0006287945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013057,0.00009334657,0.00022872277,0.050442927,0.00042684688,0.000119594006,0.00007417395,0.00029771248,0.00047535112,0.0036663502,0.018731099,0.9253134],"study_design_scores_gemma":[0.0003292483,0.0003410101,0.002523805,0.07863509,0.0020084006,0.0013931347,0.00015562617,0.00029111365,0.0003056786,0.004653778,0.90931576,0.00004725419],"about_ca_topic_score_codex":0.0015862272,"about_ca_topic_score_gemma":0.0048697665,"teacher_disagreement_score":0.004064015,"about_ca_system_score_codex":0.00081517565,"about_ca_system_score_gemma":0.0020884085,"threshold_uncertainty_score":0.013595521},"labels":[],"label_agreement":null},{"id":"W4402312879","doi":"10.1007/s11899-024-00742-x","title":"Advances in Stem Cell Transplantation for Myelofibrosis","year":2024,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Transplantation; Hematology; Stem cell; Internal medicine; Oncology; Intensive care medicine; Biology; Bone marrow; Genetics","score_opus":0.06258721104371225,"score_gpt":0.38268654524185536,"score_spread":0.3200993341981431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402312879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049651237,0.999265,0.000070899245,0.00012524913,0.00013419765,0.0000022496326,0.000010251869,0.000003422996,0.00033906577],"genre_scores_gemma":[0.00042588913,0.9987483,0.00014726484,0.00022255677,0.00024926793,0.0000032937462,0.000024291068,0.0000011963497,0.00017789521],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979156,0.00003844502,0.00004364184,0.000036254718,0.00007405152,0.000016161179],"domain_scores_gemma":[0.99937505,0.00038097397,0.00007891161,0.000015069264,0.00011362783,0.0000364659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083051575,0.00064676796,0.0014265705,0.0025170674,0.00024095144,0.000991531,0.0007974188,0.00076176156,0.0039347922],"category_scores_gemma":[0.0013149306,0.0002179709,0.0006219969,0.0021497838,0.00041485677,0.0012024295,0.0006365937,0.0017440892,0.0013719271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070009555,0.000047827452,0.00018407244,0.016313229,0.000097527714,0.00012941707,0.000028336828,0.00022184898,0.00071138877,0.0016239118,0.019403854,0.9611685],"study_design_scores_gemma":[0.00006750095,0.00017787168,0.0013457227,0.009486563,0.000497694,0.0020346942,0.000061700695,0.00016136908,0.00058912137,0.0021910863,0.98335636,0.000030312573],"about_ca_topic_score_codex":0.00069402234,"about_ca_topic_score_gemma":0.0014172541,"teacher_disagreement_score":0.0039347922,"about_ca_system_score_codex":0.00037013847,"about_ca_system_score_gemma":0.00095388707,"threshold_uncertainty_score":0.013163209},"labels":[],"label_agreement":null},{"id":"W4413100643","doi":"10.1007/s11899-025-00754-1","title":"Allogeneic Transplant for CMML","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematology; Internal medicine; Oncology; Intensive care medicine","score_opus":0.09515401914913654,"score_gpt":0.4224962066267783,"score_spread":0.32734218747764177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413100643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006468918,0.98465884,0.00044128034,0.0020912895,0.0047935448,0.000056611363,0.00030050517,0.000057712292,0.006953416],"genre_scores_gemma":[0.004935275,0.9795364,0.00053475075,0.0040723328,0.0071274703,0.00005361409,0.0008255837,0.000031498657,0.0028830436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970263,0.00006829313,0.000067661764,0.000043470238,0.00009455591,0.000023431521],"domain_scores_gemma":[0.9994305,0.00022544601,0.00016950775,0.000019300849,0.00009957029,0.000055601107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005301218,0.000583336,0.00089132757,0.0010122629,0.00019979617,0.0009971401,0.00056603726,0.00080945384,0.015226555],"category_scores_gemma":[0.001829798,0.00012240454,0.0007474063,0.0006984643,0.00021630756,0.0007126501,0.0005168617,0.0010996829,0.0052208463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020250268,0.00003893851,0.0006095035,0.02738153,0.00026845725,0.00063122873,0.00004245003,0.00018382914,0.00091766467,0.002225575,0.15197754,0.81552076],"study_design_scores_gemma":[0.00006778051,0.00013885816,0.001617746,0.020077273,0.00041405996,0.0065163677,0.000052247306,0.00007688709,0.000620398,0.001614838,0.9687838,0.000019768753],"about_ca_topic_score_codex":0.0003028677,"about_ca_topic_score_gemma":0.0004009133,"teacher_disagreement_score":0.015226555,"about_ca_system_score_codex":0.00040029344,"about_ca_system_score_gemma":0.00088460505,"threshold_uncertainty_score":0.05093783},"labels":[],"label_agreement":null},{"id":"W4415987224","doi":"10.1007/s11899-025-00764-z","title":"Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Blinatumomab; Chimeric antigen receptor; Ponatinib; Immunotherapy; Hematology; Minimal residual disease; Chemotherapy","score_opus":0.03765103770373049,"score_gpt":0.34985800668731853,"score_spread":0.312206968983588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415987224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064839456,0.9992436,0.000067461544,0.00013073023,0.00013367669,0.000003224081,0.000007905039,0.0000036415145,0.00034489122],"genre_scores_gemma":[0.0003687852,0.9989728,0.00009861654,0.00017252585,0.00010694561,0.0000034296954,0.00001569604,7.9170434e-7,0.00026052288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998252,0.00003628067,0.000020597872,0.000027420896,0.00007038661,0.00002011729],"domain_scores_gemma":[0.99975115,0.00012523516,0.000040764633,0.0000062101735,0.00005350536,0.000023119916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006468053,0.0007419452,0.0013965566,0.0016097425,0.00017277374,0.00097546383,0.00090366934,0.0009918171,0.0027296217],"category_scores_gemma":[0.00065481395,0.00022162993,0.00045752001,0.0018641789,0.00043192785,0.0009485951,0.00053558545,0.0020252494,0.0014753395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012658989,0.00009307167,0.00010554763,0.0143931545,0.00008781698,0.00012764591,0.000034705947,0.00044225063,0.0021234641,0.0029506062,0.027058667,0.9524566],"study_design_scores_gemma":[0.00005843212,0.00016600723,0.00047159437,0.002830986,0.00015372763,0.0006571169,0.000036371923,0.000115481525,0.0005544287,0.0011357039,0.99380577,0.000014344105],"about_ca_topic_score_codex":0.0010897149,"about_ca_topic_score_gemma":0.002008271,"teacher_disagreement_score":0.0027296217,"about_ca_system_score_codex":0.0005012531,"about_ca_system_score_gemma":0.00086970377,"threshold_uncertainty_score":0.009131491},"labels":[],"label_agreement":null},{"id":"W818882356","doi":"10.1007/s11899-015-0272-3","title":"Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Flow cytometry; Bone marrow; Hematology; International Prognostic Scoring System; Internal medicine; Biopsy; Pathology; Cytology; Oncology; Immunology","score_opus":0.15034249218147458,"score_gpt":0.4220731153203322,"score_spread":0.27173062313885765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W818882356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012490821,0.9982705,0.00014202118,0.0007385045,0.00022649145,0.0000039152355,0.000020914307,0.000007569591,0.00046514175],"genre_scores_gemma":[0.0014414877,0.9961056,0.00057560636,0.0010670652,0.00048032936,0.0000073371793,0.000054923614,0.0000023987727,0.00026520793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999423,0.00014600185,0.0001018575,0.000091308655,0.00020309396,0.000034743294],"domain_scores_gemma":[0.99779886,0.0014288996,0.0002186208,0.000049296166,0.00042394755,0.00008038684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015085068,0.00057447015,0.001972682,0.0020413848,0.00021742789,0.0013356858,0.0013644411,0.0012216404,0.0024980155],"category_scores_gemma":[0.0040073954,0.00021295028,0.0008554897,0.0014345086,0.00072626217,0.0015312101,0.0005749919,0.0019117966,0.0011819814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009663709,0.00004243013,0.0018510137,0.009176891,0.00013890283,0.00027310266,0.000042373194,0.00012879755,0.00073020504,0.001525857,0.022601329,0.9633925],"study_design_scores_gemma":[0.00009573488,0.00018785604,0.007959182,0.020573879,0.00079824275,0.0054016183,0.00024065221,0.00020908425,0.0010470926,0.0033334852,0.96009374,0.000059245052],"about_ca_topic_score_codex":0.0015696619,"about_ca_topic_score_gemma":0.0022843578,"teacher_disagreement_score":0.0024980155,"about_ca_system_score_codex":0.0005201138,"about_ca_system_score_gemma":0.0014327542,"threshold_uncertainty_score":0.008356631},"labels":[],"label_agreement":null}]}